Details for New Drug Application (NDA): 017986
✉ Email this page to a colleague
The generic ingredient in MINIZIDE is polythiazide; prazosin hydrochloride. There is one drug master file entry for this compound. Additional details are available on the polythiazide; prazosin hydrochloride profile page.
Summary for 017986
Tradename: | MINIZIDE |
Applicant: | Pfizer |
Ingredient: | polythiazide; prazosin hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 0.5MG;EQ 1MG BASE | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 0.5MG;EQ 2MG BASE | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 0.5MG;EQ 5MG BASE | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017986
Complete Access Available with Subscription